Skip to main content
. Author manuscript; available in PMC: 2013 Aug 21.
Published in final edited form as: Addiction. 2010 Sep;105(9):1660–1668. doi: 10.1111/j.1360-0443.2010.03020.x

Table 3.

Adverse Events Reported By At Least 5% of Participants During Treatment

Adverse Event Selegiline Placebo
Insomnia 47.1% 42.6%
Headache 33.9% 35.2%
Skin rash 24.8% 20.5%
Racing thoughts 20.7% 23.0%
Lightheaded 16.5% 16.4%
Vivid Dreams 10.7% 9.8%
Other 42% 35%

No effects of treatment: all p-values > .05